ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
14.00
0.00 (0.00%)
Oct 31, 2025, 4:00 PM EDT
ZIVO Bioscience Revenue
ZIVO Bioscience had revenue of $53.40K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $174.90K, up 194.84% year-over-year. In the year 2024, ZIVO Bioscience had annual revenue of $157.22K with 468.61% growth.
Revenue (ttm)
174.90K
Revenue Growth
+194.84%
P/S Ratio
310.41
Revenue / Employee
24.99K
Employees
7
Market Cap
54.29M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 157.22K | 129.57K | 468.61% |
| Dec 31, 2023 | 27.65K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 20.00K | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Northwest Biotherapeutics | 1.09M |
ZIVO Bioscience News
- 24 days ago - Insider Buying: Christopher Maggiore Acquires Additional Shares of Zivo Bioscience Inc (ZIVO) - GuruFocus
- 7 weeks ago - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses - Business Wire
- 4 months ago - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry - Business Wire
- 6 months ago - University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - Business Wire
- 9 months ago - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Business Wire
- 10 months ago - ZIVO Bioscience to Present at The Microcap Conference 2025 - Business Wire
- 11 months ago - ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Business Wire
- 11 months ago - ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Business Wire